• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旨在揭示胆管癌高恶性程度关键决定因素的计算分析。

Computational analyses to reveal the key determinants of the high malignancy level of cholangiocarcinoma.

作者信息

Li Xuan, Liu Aoran, Mu Xuechen, Wang Zhihang, Xiao Jun, Qu Yinwei, Huang Zhenyu, Zhang Ye, Xu Ying

机构信息

Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun 130012, Jilin Province, China.

School of Medicine, Southern University of Science and Technology, Shenzhen 518055, Guangdong Province, China.

出版信息

J Transl Int Med. 2025 Jan 10;12(6):602-617. doi: 10.1515/jtim-2024-0033. eCollection 2024 Dec.

DOI:10.1515/jtim-2024-0033
PMID:40708677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12288948/
Abstract

BACKGROUND AND OBJECTIVES

Cholangiocarcinoma (CHOL) is a rare and highly aggressive cancer that originates in the bile duct; it has an average five-year survival rate of 9%, which makes it the cancer with the lowest survival rate among all 33 cancer types in the cancer genome atlas (TCGA) Program. The aim of this study is to elucidate the key determinants of the high malignancy level of CHOL through computational and cell-based experimental approaches and, particularly, to investigate how bile acids (BAs) influence CHOL's propensity to metastasize.

METHODS

Our study analyzed the transcriptomic data from 1835 tissue samples of 7 digestive system cancer types in the TCGA database and compared them with those of 330 control tissue samples. Multiple cellular and molecular factors were considered in the study, including the level of hypoxia, level of immune cell infiltration, degree of cellular dedifferentiation, and level of sialic acid (SA) accumulation on the surface of cancer cells. Using these factors, we developed a multivariable regression model for the five-year survival rate, as reported by the Surveillance, Epidemiology, and End Results (SEER) Program reports, and analyzed how BA biology influences a few of these factors and causes CHOL to have a high malignancy level.

RESULTS

CHOL exhibited the highest level of SA accumulation and B-cell infiltration among all cancer types studied. BAs inhibit the cell cycle progression through the receptor , thereby limiting the rate of nucleotide biosynthesis-which in turn forces the cells to increase SA biosynthesis in order to maintain the intracellular pH at a stable level-thereby driving cell migration and metastasis, as established in our previous study.

CONCLUSIONS

BAs are the key contributors to the lowest five-year survival rate of CHOL among the seven cancer types studied here. This finding not only reveals the molecular mechanisms underlying the high malignancy level of CHOL but also provides a new potential target for the diagnosis and treatment of CHOL.

摘要

背景与目的

胆管癌(CHOL)是一种起源于胆管的罕见且侵袭性很强的癌症;其平均五年生存率为9%,这使其成为癌症基因组图谱(TCGA)计划中33种癌症类型里生存率最低的癌症。本研究的目的是通过计算和基于细胞的实验方法阐明胆管癌高恶性水平的关键决定因素,特别是研究胆汁酸(BAs)如何影响胆管癌的转移倾向。

方法

我们的研究分析了TCGA数据库中7种消化系统癌症类型的1835个组织样本的转录组数据,并将其与330个对照组织样本的数据进行比较。研究中考虑了多个细胞和分子因素,包括缺氧水平、免疫细胞浸润水平、细胞去分化程度以及癌细胞表面唾液酸(SA)积累水平。利用这些因素,我们根据监测、流行病学和最终结果(SEER)计划报告中所报道的五年生存率建立了一个多变量回归模型,并分析了胆汁酸生物学如何影响其中一些因素并导致胆管癌具有高恶性水平。

结果

在所有研究的癌症类型中胆管癌表现出最高水平的唾液酸积累和B细胞浸润。如我们之前的研究所证实,胆汁酸通过受体抑制细胞周期进程,从而限制核苷酸生物合成速率,这反过来迫使细胞增加唾液酸生物合成以将细胞内pH维持在稳定水平,进而驱动细胞迁移和转移。

结论

胆汁酸是此处研究的七种癌症类型中胆管癌五年生存率最低的关键因素。这一发现不仅揭示了胆管癌高恶性水平的分子机制,还为胆管癌的诊断和治疗提供了一个新的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1745d2082a24/j_jtim-2024-0033_fig_007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/91ba1cb420ec/j_jtim-2024-0033_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/509b4b1c0f0f/j_jtim-2024-0033_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1ad6bb5810c2/j_jtim-2024-0033_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1011566d53ae/j_jtim-2024-0033_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/900a881a159b/j_jtim-2024-0033_fig_005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/bbf5051751ca/j_jtim-2024-0033_fig_006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1745d2082a24/j_jtim-2024-0033_fig_007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/91ba1cb420ec/j_jtim-2024-0033_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/509b4b1c0f0f/j_jtim-2024-0033_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1ad6bb5810c2/j_jtim-2024-0033_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1011566d53ae/j_jtim-2024-0033_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/900a881a159b/j_jtim-2024-0033_fig_005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/bbf5051751ca/j_jtim-2024-0033_fig_006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7c/12288948/1745d2082a24/j_jtim-2024-0033_fig_007.jpg

相似文献

1
Computational analyses to reveal the key determinants of the high malignancy level of cholangiocarcinoma.旨在揭示胆管癌高恶性程度关键决定因素的计算分析。
J Transl Int Med. 2025 Jan 10;12(6):602-617. doi: 10.1515/jtim-2024-0033. eCollection 2024 Dec.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

引用本文的文献

1
Advanced omics approaches in liver transplant settings: current applications and future prospectives.肝移植环境中的先进组学方法:当前应用与未来展望。
Front Immunol. 2025 Jul 11;16:1564248. doi: 10.3389/fimmu.2025.1564248. eCollection 2025.

本文引用的文献

1
Comparison of gene set scoring methods for reproducible evaluation of tuberculosis gene signatures.比较基因集评分方法,以实现结核病基因特征的可重现性评估。
BMC Infect Dis. 2024 Jun 20;24(1):610. doi: 10.1186/s12879-024-09457-z.
2
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report.最初诊断为不明原发腺癌伴肝十二指肠韧带淋巴结转移的肝内胆管癌:一例报告。
Oncol Lett. 2023 Nov 8;27(1):7. doi: 10.3892/ol.2023.14140. eCollection 2024 Jan.
3
Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management.
细胞膜唾液酸组:唾液酸作为人类癌症治疗中的治疗靶点和耐药性调节剂
Cancers (Basel). 2023 Oct 22;15(20):5103. doi: 10.3390/cancers15205103.
4
Sialic acid: an attractive biomarker with promising biomedical applications.唾液酸:一种具有前景广阔的生物医学应用的有吸引力的生物标志物。
Asian Biomed (Res Rev News). 2022 Aug 31;16(4):153-167. doi: 10.2478/abm-2022-0020. eCollection 2022 Aug.
5
Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review.近年来唾液酸转移酶抑制剂在控制癌症转移方面的研究进展:综述。
Biomed Pharmacother. 2023 Sep;165:115091. doi: 10.1016/j.biopha.2023.115091. Epub 2023 Jul 6.
6
Nucleotide metabolism: a pan-cancer metabolic dependency.核苷酸代谢:一种泛癌代谢依赖性。
Nat Rev Cancer. 2023 May;23(5):275-294. doi: 10.1038/s41568-023-00557-7. Epub 2023 Mar 27.
7
GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma.G蛋白偶联胆汁酸受体1(GPBAR1)与肝细胞癌的异时性骨转移及不良预后相关。
Front Oncol. 2023 Jan 23;12:1113785. doi: 10.3389/fonc.2022.1113785. eCollection 2022.
8
The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.固有免疫细胞在肿瘤微环境中的作用及抗肿瘤治疗的研究进展。
Front Immunol. 2023 Jan 19;13:1039260. doi: 10.3389/fimmu.2022.1039260. eCollection 2022.
9
Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment.唾液酸转移酶和神经氨酸酶:癌症治疗的潜在靶点。
Diseases. 2022 Nov 28;10(4):114. doi: 10.3390/diseases10040114.
10
Molecular bases of morphologically diffused tumors across multiple cancer types.多种癌症类型中形态学上弥漫性肿瘤的分子基础。
Natl Sci Rev. 2022 Aug 26;9(11):nwac177. doi: 10.1093/nsr/nwac177. eCollection 2022 Nov.